LILLY ELI & CO
Insider CIK 59478 · CLCD 10% owner · CERU 10% owner · ZYME 10% owner · RCPT 10% owner · LPTX 10% owner · CHRS · DERM 10% owner · RNA 10% owner · AGLE 10% owner · PRVL 10% owner · AKUS 10% owner · ELAN 10% owner · SGTX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SGTX Sigilon Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-14 | 1,718,493 | $14.92 | $25.64M | 100 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2022-11-30 | 2022-12-01 | 29,992,668 | $12.50 | $374.91M | 100 | SEC↗ |
| PRVL Prevail Therapeutics Inc. | P Buy | 2021-01-22 | 2021-01-22 | 34,284,789 | $22.50 | $771.41M | 100 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 888,888 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion deriv | 2020-12-08 | 2020-12-10 | 1,555,555 | — | $0 | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | C Conversion | 2020-12-08 | 2020-12-10 | 2,444,443 | — | $0 | 2,444,443 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | P Buy | 2020-12-08 | 2020-12-10 | 300,000 | $18.00 | $5.40M | 2,744,443 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion deriv | 2020-06-16 | 2020-06-16 | 4,576,342 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | C Conversion | 2020-06-16 | 2020-06-16 | 2,169,396 | — | $0 | 2,169,396 | SEC↗ |
| DERM Dermira, Inc. | P Buy | 2020-02-20 | 2020-02-20 | 40,926,025 | $18.75 | $767.36M | 100 | SEC↗ |
| ELAN Elanco Animal Health Inc | D To issuer | 2019-03-11 | 2019-03-11 | 293,290,000 | — | $0 | 0 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2019-01-31 | 2019-02-04 | 250,000 | $16.00 | $4.00M | 2,898,647 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-11-06 | 2018-11-08 | 700,000 | $14.00 | $9.80M | 3,148,647 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-09-24 | 2018-09-26 | 2,027 | $16.36 | $33.2K | 3,848,647 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-09-18 | 2018-09-20 | 6,870 | $14.56 | $100.0K | 3,850,674 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-09-17 | 2018-09-18 | 6,865 | $14.58 | $100.1K | 3,857,544 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-09-14 | 2018-09-18 | 9,009 | $14.58 | $131.4K | 3,864,409 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-09-13 | 2018-09-14 | 20,900 | $14.32 | $299.3K | 3,873,418 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-09-12 | 2018-09-14 | 10,059 | $14.83 | $149.2K | 3,894,318 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-09-11 | 2018-09-12 | 11,277 | $14.87 | $167.7K | 3,904,377 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-09-10 | 2018-09-12 | 4,500 | $14.44 | $65.0K | 3,915,654 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-08-31 | 2018-09-04 | 700 | $14.26 | $10.0K | 3,920,154 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-08-30 | 2018-08-31 | 3,440 | $14.35 | $49.4K | 3,920,854 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-08-29 | 2018-08-31 | 2,312 | $14.26 | $33.0K | 3,924,294 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-08-14 | 2018-08-16 | 3,000 | $14.28 | $42.8K | 3,926,606 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-08-13 | 2018-08-14 | 4,531 | $14.33 | $64.9K | 3,929,606 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-08-10 | 2018-08-14 | 1,898 | $14.28 | $27.1K | 3,934,137 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-08-03 | 2018-08-07 | 1,650 | $13.55 | $22.4K | 3,936,035 | SEC↗ |
| ZYME Zymeworks Inc. | S Sale | 2018-08-02 | 2018-08-03 | 19,400 | $13.31 | $258.2K | 3,937,685 | SEC↗ |
| LPTX LEAP THERAPEUTICS, INC. | A Award deriv | 2018-07-30 | 2018-08-13 | 331,221 | — | $0 | 331,221 | SEC↗ |
| CLCD CoLucid Pharmaceuticals, I | J Other | 2017-03-01 | 2017-03-01 | 19,285,108 | $46.50 | $896.76M | 100 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion deriv | 2016-04-12 | 2016-04-14 | 1,120,448 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion deriv | 2016-04-12 | 2016-04-14 | 890,476 | — | $0 | 0 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion | 2016-04-12 | 2016-04-14 | 2,010,924 | — | $0 | 2,068,543 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | P Buy | 2016-04-12 | 2016-04-14 | 500,000 | $10.00 | $5.00M | 2,568,543 | SEC↗ |
| AGLE Aeglea BioTherapeutics, In | C Conversion | 2016-04-12 | 2016-04-14 | 2,010,924 | — | $0 | 2,068,543 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 2,333,955 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion deriv | 2014-11-12 | 2014-11-12 | 543,101 | — | $0 | 0 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 2,333,955 | — | $0 | 2,333,955 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | P Buy | 2014-11-12 | 2014-11-12 | 164,963 | $13.50 | $2.23M | 3,042,019 | SEC↗ |
| CHRS Coherus BioSciences, Inc. | C Conversion | 2014-11-12 | 2014-11-12 | 543,101 | — | $0 | 2,877,056 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 13,513,513 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 0 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 0 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion deriv | 2014-04-15 | 2014-04-15 | 4,340,831 | — | $0 | 0 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 192,209 | — | $0 | 1,422,907 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 299,213 | — | $0 | 1,230,698 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 199,875 | — | $0 | 1,622,782 | SEC↗ |
| CERU Cerulean Pharma Inc. | P Buy | 2014-04-15 | 2014-04-15 | 733,445 | $7.00 | $5.13M | 2,356,227 | SEC↗ |
| CERU Cerulean Pharma Inc. | C Conversion | 2014-04-15 | 2014-04-15 | 931,485 | — | $0 | 931,485 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-11-21 | 0 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-11-21 | 0 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | P Buy | 2013-05-14 | 2013-11-21 | 142,857 | $14.00 | $2.00M | 2,081,210 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-11-21 | 1,152,039 | $5.25 | $6.05M | 1,266,324 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-11-21 | 672,029 | $7.73 | $5.19M | 1,938,353 | SEC↗ |